
Jeff Cranmer
PersonJeff Cranmer is an executive editor at BioCentury, where he leads the publication's daily global intelligence and coordinates coverage of financings and clinical-trial data. He is also the host of BioCentury This Week.
What Jeff Cranmer has said on podcasts
1 statement
China biopharma deal count has already surpassed prior full-year totals.
“This year's China deal count already exceeds that of prior years, and it's only October.”
Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winnersListen at 0:01
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.